Limburgse Reconversie Maatschappij

Type

Private equity

Status

Active

Location

Hasselt, Belgium

Total investments

85

Average round size

3M

Portfolio companies

68

Rounds per year

2.83

Lead investments

6

Follow on index

0.20

Exits

12

Stages of investment
SeedEarly Stage Venture
Areas of investment
BiotechnologySoftwareInformation TechnologyHuman ResourcesInformation ServicesHealth CareSaaSAppsManufacturingMedical

Summary

Limburgse Reconversie Maatschappij appeared to be the VC, which was created in 1994. The company was established in Europe in Belgium. The main office of represented VC is situated in the Hasselt.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Limburgse Reconversie Maatschappij, startups are often financed by Vesalius Biocapital Partners, Sebastien de Halleux, Peter Hinssen. The meaningful sponsors for the fund in investment in the same round are Vesalius Biocapital Partners, Gemma Frisius Fund, PMV. In the next rounds fund is usually obtained by PMV, Vesalius Biocapital Partners, Split Rock Partners.

The overall number of key employees were 6.

The common things for fund are deals in the range of 1 - 5 millions dollars. The top activity for fund was in 2013. Despite it in 2019 the fund had an activity. The fund is constantly included in 2-6 investment rounds annually. This Limburgse Reconversie Maatschappij works on 16 percentage points less the average amount of lead investments comparing to the other organizations. The typical startup value when the investment from Limburgse Reconversie Maatschappij is 5-10 millions dollars. Speaking about the real fund results, this VC is 5 percentage points less often commits exit comparing to other organizations. The higher amount of exits for fund were in 2018.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - Belgium. We can highlight the next thriving fund investment areas, such as Medical, Information Technology. Among the most popular portfolio startups of the fund, we may highlight Promethera Biosciences, Blue Foot Membranes, Soulco. The fund has no exact preference in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.

Show more

Investor highlights

Stage focus
Seed

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
85
Lead investments
6
Exits
12
Rounds per year
2.83
Follow on index
0.20
Investments by industry
  • Information Technology (27)
  • Software (23)
  • Health Care (12)
  • Biotechnology (11)
  • Manufacturing (11)
  • Show 110 more
Investments by region
  • Belgium (72)
  • United States (5)
  • United Kingdom (2)
  • Germany (2)
  • Netherlands (3)
  • Show 1 more
Peak activity year
2013

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
13
Avg. valuation at time of investment
1M
Group Appearance index
0.59
Avg. company exit year
13
Avg. multiplicator
0.51

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Luzmo 25 Nov 2020 Seed 4M Vlaams-Brabant, Leuven, Belgium
Papricut.com 01 Jan 2024 Seed 5K Dubai, United Arab Emirates
Ticto 08 Dec 2017 Information Technology, Information Services, Cyber Security, Network Security, Security Early Stage Venture 2M United States, California, San Francisco

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.